Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.07 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.075 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |